Abstract

:Objective To explore theprevalence of metabolic syndrome( MetS) and its components in patients with bipolardisorder and their lifestyle. Methods Collected 148 cases of bipolar disorder in patientswith body mass index (BMI),blood glucose,blood pressure,triglyceride(TG),high-densitylipoprotein( HDL-C) etc, and self-compiled scale was used to assess their lifestyle. Allpatients were followed 6 months. The patients werecompared with 65 normal controls.Results The patients group in the baseline period,treatment after 1 months,3 months and 6months,the incidence of MetS was as followed:11.5% ,15.5% ,18.2% ,20.9%. The patients atall stages,the incidence of MetS,BMI≥25kg/m2 ,high TG levels,low HDL-C levels and hypertensionwere significantly higher than the control (P<0.01). After 6 months of treatment theincidence of MetS,hypertriglyceridemia were higher than baseline (P < 0.05). Thepatients group' s work intensity, frequency of exercise, eat more than 3 times per daycompared with the control group were significantly different (P<0.01, P<0.05).Conclusion The incidence of MetS and hyperuricemia in patients with bipolar disorder aftertreatment is higher than the control group; as a continuation of the treatment,theincidence of metabolic abnormalities increased gradually. Unhealthy lifestyle, lack ofexercise,unreasonable diet maybe increase the risk of metabolic disorders. Key words: Bipolardisorder; Metabolic syndrome; Lifestyle

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.